Japan Tissue Engineering Co., Ltd. provided earnings guidance for the year ending March 31, 2023. For the year, the company expects net sales of ¥2,540 million, operating loss of ¥389 million and net loss of ¥388 million or ¥9.57 per share.
Japan Tissue Engineering Co., Ltd.
Equities
7774
JP3389610001
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
712 JPY | -0.84% | +7.55% | +40.71% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.71% | 179M | |
+14.21% | 129B | |
-7.72% | 10.98B | |
-1.95% | 8.22B | |
+40.43% | 5.76B | |
-27.04% | 4.41B | |
+7.47% | 3.41B | |
-15.26% | 2.7B | |
-12.01% | 2.1B | |
-13.56% | 1.91B |
- Stock Market
- Equities
- 7774 Stock
- News Japan Tissue Engineering Co., Ltd.
- Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2023